Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel
NASDAQ:ONCO

Onconetix Q2 2026 Earnings Report

Onconetix logo
$0.90 -0.10 (-10.08%)
Closing price 08/6/2026 04:00 PM Eastern
Extended Trading
$0.90 0.00 (-0.52%)
As of 09:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Onconetix EPS Results

Actual EPS
N/A
Consensus EPS
-$4,505.00
Beat/Miss
N/A
One Year Ago EPS
N/A

Onconetix Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.02 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Onconetix Announcement Details

Quarter
Q2 2026
Date
8/17/2026
Time
N/A
Conference Call Date
Wednesday, August 12, 2026
Conference Call Time
9:30AM ET

Conference Call Resources

Onconetix Earnings Headlines

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
August 6 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340287/0/en/onconetix-acquisition-target-realbotix-secures-agreement-for-humanoid-robot-appearance-on-emmy-award-winning-streaming-series.html
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
August 5 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339298/0/en/onconetix-announces-appointment-of-ralph-schiess-phd-to-board-of-directors-of-proteomedix-ag.html
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
August 7 at 1:00 AM  |  Base Camp Trading (Ad)
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323233/0/en/onconetix-highlights-realbotix-partnership-with-bloom-services-to-launch-uk-pilot-using-humanoid-robots-to-combat-elderly-social-isolation.html
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
June 24, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/onconetix-highlights-realbotix-s-launch-of-humanoid-robot-and-ai-teachers-assistant-pilot-program-in-new-york-state-school-district-1036271876
Onconetix Announces Realbotix Optio and M-Series Humanoid Robot Pilot at Salamanca City Central School District
June 24, 2026  |  quiverquant.comQ
See More Onconetix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Onconetix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Onconetix and other key companies, straight to your email.

About Onconetix

Onconetix (NASDAQ:ONCO), a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

View Onconetix Profile
Earnings Tools